Carey Olsen advises NorthStrive Acquisition Corp I on US$350 million business combination with Nuclea Energy
Carey Olsen has advised NorthStrive Acquisition Corp I ("NorthStrive") on the Cayman Islands legal aspects of its proposed business combination with Nuclea Energy Inc. ("Nuclea"), an advanced nuclear technology company, in a transaction implying an enterprise value for Nuclea of US$350 million.
NorthStrive is a special purpose acquisition company incorporated as a Cayman Islands exempted company and listed on Nasdaq. Under the terms of the business combination agreement, NorthStrive will deregister as a Cayman Islands exempted company and continue into Canada under the Canada Business Corporations Act.
Nuclea will subsequently amalgamate with a wholly owned subsidiary of NorthStrive, with the combined company expected to operate as Nuclea-X Inc. and list on Nasdaq. The transaction is expected to complete in the first half of 2027, subject to customary shareholder, regulatory and other closing conditions.
Headquartered in Mississauga, Ontario, Nuclea develops advanced nuclear technologies focused on the provision of reliable, zero-emission energy. Its technology portfolio includes the Morpheus Micro Modular Reactor, while its pending acquisition of Moltex is intended to support the development of a closed nuclear fuel cycle incorporating nuclear fuel recycling technology and advanced reactor systems.
The Carey Olsen team advising NorthStrive comprised partner Dylan Wiltermuth, and associate
Nicholas Vasic.
Dylan Wiltermuth said: "We are delighted to have advised NorthStrive on the Cayman Islands aspects of this significant transaction. The proposed business combination represents an important milestone for NorthStrive and Nuclea, and demonstrates the continued role of Cayman Islands structures in sophisticated cross-border capital markets transactions. We look forward to supporting NorthStrive as the transaction progresses towards completion."